Wyeth, and its dividions Wyeth Pharmaceuticals Inc. and ESI Lederle | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Wyeth, and its dividions Wyeth Pharmaceuticals Inc. and ESI Lederle

Sort by

Viewing results 1‒25 of 203

Pfizer Inc
Pfizer pins hopes on record pipeline to recover from post-Covid hangover
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
February 21, 2023
US & Canadian companies
Pfizer boss humbled after ‘man to man’ talk with Donald Trump
...“The optics here proved to be far more important than he might have appreciated and it’s come back to bite him.”...
July 13, 2018
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
LexUS & Canadian companies
Pfizer: shelf medication Premium content
...The current version, mostly acquired with Wyeth in 2009, includes brands such as Centrum supplements and ChapStick....
October 10, 2017
US & Canadian companies
Pfizer weighs sale of consumer health business
...But it subsequently took on a new portfolio when it acquired Wyeth in 2010....
October 10, 2017
US & Canadian companies
Pharma whistleblower takes total payouts close to $100m
...for its Protonix heartburn drug....
February 16, 2016
LexTax
Pfizer: Clinton/Read 2016
...And one of the key — and legitimate — sources of returns from mergers is sacking people. Before Pfizer bought Wyeth in 2009, the two companies employed 124,000 people. Pfizer now employs 78,000....
October 29, 2015
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexUS & Canadian companies
Pfizer / Allergan: history will not repeat
...company; cost savings reminiscent of the Wyeth deal; and, of course, a very low tax rate....
November 23, 2015
Strategy
Information matchmaker looks beyond Wall Street
...Martoma had obtained non-public information about an experimental drug for Alzheimer’s that was being developed by listed companies Elan and Wyeth....
June 1, 2016
News in-depthUS & Canadian companies
Pfizer looks to bulk up in era of slimming down
...When Pfizer revealed its most recent mega-merger, the $68bn takeover of Wyeth in 2009, Jeffrey Kindler, then chief executive, hailed the deal as “a powerful opportunity to transform our industry”....
November 23, 2015
US & Canadian companies
Pfizer’s Ian Read looks to count Allergan merger as his legacy
...The marriage between the makers of Viagra and Botox would, if consummated, create the world’s biggest pharmaceuticals group....
November 27, 2015
News in-depthUS & Canadian companies
Pfizer-Allergan tie-up would mark M&A high point
...However, a Pfizer-Allergan tie-up, would be the first full-scale combination between two top-20 pharma groups since Pfizer bought Wyeth and Merck acquired Schering-Plough in 2009....
November 22, 2015
Pharmaceuticals sector
Big Pharma has become addicted to an illusion
...for $90bn in 2000 and Wyeth for $68bn in 2009, were formed....
November 25, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the gross domestic product of Austria....
April 26, 2015
US & Canadian companies
Drug output at heart of Pfizer deal debate
...Since 2000, the US company has ploughed about $100bn into drug development – more than any other pharmaceutical company and one-third more than AstraZeneca....
May 12, 2014
LexPharmaceuticals sector
Pfizer / AstraZeneca: combination therapy
...Modern Pfizer, with its $193bn market capitalisation, is cost-reduction via mega-merger made flesh. Its last big deal, $68bn for Wyeth in 2009, began with $4bn in promised savings....
April 21, 2014
FT Live
Attracting and Retaining Global Talent
How are countries, cities and companies competing for the best workforce?
Wednesday, 24 April44 Grosvenor Sq, London W1K 2HP, UK
Person in the NewsAndrew Ward
Ian Read: the pragmatist out to transform the drugs industry
...A year before, Pfizer had bought Wyeth, a rival drugmaker, for $68bn. It was the latest in a succession of large deals that greatly increased Pfizer’s scale but had done little for shareholder returns....
May 2, 2014
US & Canadian companies
Pfizer chief executive pins faith on its powers of persuasion
...Some analysts have expressed puzzlement over Pfizer’s move, which seems at odds with Mr Read’s efforts in recent years to slim down the group after a series of megadeals such as its $69bn takeover of Wyeth...
April 29, 2014
The FT ViewUK companies
Science and the UK merger regime
...Since acquiring large US rival Wyeth in 2009, it has cut its research budget from $11bn to $6.7bn. To believe it would act differently with AstraZeneca seems simply naive....
May 6, 2014
US & Canadian companies
Big pharma deals are back in the mix
...In the five years since Pfizer bought Wyeth, it has cut about half the total research and development spending made by the two companies the year before the deal....
April 21, 2014
US & Canadian companies
Pfizer sets stage for corporate showdown
...For Pfizer, a deal would add to its history of megamergers, including its $69bn takeover of Wyeth in 2009 and its $111.8bn deal with Warner-Lambert in 2000....
April 28, 2014
US & Canadian companies
AstraZeneca US shares jump as details of Pfizer talks revealed
...Pfizer has a history of big acquisitions, such as its $68bn takeover of Wyeth in 2009 and its $56bn deal with Pharmacia in 2002....
April 22, 2014
Pharmaceuticals sector
Bid puts Pfizer’s DNA under microscope
...While other pharmaceutical groups have grown through developing and commercialising their own products, the US giant has maintained its leading position in large part through takeovers....
May 2, 2014
Inside BusinessSarah Gordon
Pfizer-AstraZeneca marriage divides opinion
...Cost savings from its last big deal – the takeover of Wyeth in 2009 – are difficult to measure, as is so often the case for anyone trying to analyse the consequences of a deal....
April 30, 2014
US & Canadian companies
Chuka Umunna attacks Pfizer for record of ‘asset-stripping’
...“There is its acquisition of Warner-Lambert in 2000 in the US; Pharmacia in Sweden in 2003; and Wyeth in the US in 2000, and that led to deep cuts in the research facilities, it led to intellectual asset-stripping...
May 2, 2014
FT AlphavilleLondon fights for its future
Pfizer and an eminent reputation
...Announcing measures related to the integration of Wyeth, which it acquired in 2009 for $68bn, Pfizer said it would leave the city and move 1,400 staff to a nearby site at Groton....
May 6, 2014

Previous pagePage 1 of 9Next page